Harrow Health(HROW) - 2024 Q2 - Quarterly Results

EXHIBIT 99.1 Harrow Announces Second Quarter 2024 Financial Results Second Quarter 2024 and Recent Selected Highlights: ● Record revenues of $48.9 million ● GAAP net loss of$(6.5) million ● Adjusted EBITDA of $8.8 million ● Cash and cash equivalents of$71.0 million as of June 30, 2024 ● IHEEZO® customer unit demand volume increased by 98% from the first quarter of 2024 ● IHEEZO supply agreements total 24 agreements to date in 2024, including a recent win with the largest and highest volume U.S. retina pra ...